Jefferies Financial Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,089
Closed -$1.26M 1428
2025
Q2
$1.26M Buy
+18,089
New +$1.03M 0.01% 656
2024
Q2
Sell
-2,758
Closed -$308K 1375
2024
Q1
$308K Buy
+2,758
New +$329K ﹤0.01% 1208
2023
Q4
Sell
-3,000
Closed -$489K 1647
2023
Q3
$489K Sell
3,000
-10,800
-78% -$1.9M ﹤0.01% 1070
2023
Q2
$2.53M Buy
+13,800
New +$1.99M 0.02% 586

Other funds holding ACLS

Jefferies Financial Group's ACLS Position: Q3 2025 in Review

Jefferies Financial Group sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 18,089 shares — an estimated $1.26M sold.

Jefferies Financial Group first reported a position in ACLS in Q2 2023 and held it in 4 quarters. The position peaked at $2.53M in Q2 2023. 361 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.

  • Jefferies Financial Group reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 18,089 Axcelis shares in Q3 2025, an estimated $1.26M.
  • Jefferies Financial Group first reported a position in Axcelis in Q2 2023 and held it in 4 quarters.
  • Jefferies Financial Group's Axcelis position peaked at $2.53M in Q2 2023.
  • 361 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.

Based on Jefferies Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.